Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Benefits of apixaban among venous thromboembolism patients with active cancer

Dr Alexander Cohen - Guys and St Thomas, London, UK
Benefits of apixaban among venous thromboembolism patients with active cancer ( Dr Alexander Cohen - Guys and St Thomas, London, UK )
13 Dec 2019

Inotuzumab ozogamicin and chemotherapy with or without blinatumomab in Philadelphia chromosone-negative ALL

Dr Nicholas Short - MD Anderson Cancer Center, Houston, USA
Inotuzumab ozogamicin and chemotherapy with or without blinatumomab in Philadelphia chromosone-negative ALL ( Dr Nicholas Short - MD Anderson Cancer Center, Houston, USA )
13 Dec 2019

Dasatinib vs imatinib for paediatric Ph ALL

Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA
Dasatinib vs imatinib for paediatric Ph ALL ( Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA )
12 Dec 2019

Study of quadruple combination for induction resistant myeloma reveals novel immune checkpoints

Dr Yael Cohen - Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Study of quadruple combination for induction resistant myeloma reveals novel immune checkpoints ( Dr Yael Cohen - Tel Aviv Sourasky Medical Center, Tel Aviv, Israel )
12 Dec 2019

KRd vs KTd followed by carfilzomib maintenance in newly diagnosed MM

Prof Heinz Ludwig - Wilhelmeninen Cancer Research Institute, Vienna, Austria
KRd vs KTd followed by carfilzomib maintenance in newly diagnosed MM ( Prof Heinz Ludwig - Wilhelmeninen Cancer Research Institute, Vienna, Austria )
12 Dec 2019

Updates on REGN1979 in R/R B-cell non-Hodgkins lymphoma

Dr Rajat Bannerji - Rutgers Cancer Institute of New Jersey, New Brunswick, USA
Updates on REGN1979 in R/R B-cell non-Hodgkins lymphoma ( Dr Rajat Bannerji - Rutgers Cancer Institute of New Jersey, New Brunswick, USA )
12 Dec 2019

Eligibility criteria in acute myeloid leukaemia clinical trials

Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA
Eligibility criteria in acute myeloid leukaemia clinical trials ( Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA )
12 Dec 2019

Moxetumomab pasudotox-tdfk in heavily retreated r/r hairy cell leukaemia

Dr Robert Kreitman - National Cancer Institute, Bethesda, USA
Moxetumomab pasudotox-tdfk in heavily retreated r/r hairy cell leukaemia ( Dr Robert Kreitman - National Cancer Institute, Bethesda, USA )
12 Dec 2019

Azacitidine plus nivolumab in older adults with AML or MDS

Prof Annette Hay - Queen's University, Ontario, Canada
Azacitidine plus nivolumab in older adults with AML or MDS ( Prof Annette Hay - Queen's University, Ontario, Canada )
12 Dec 2019

Venetoclax chemo combo active and well-tolerated in children with r/r AML

Dr Seth Karol - St. Jude Children’s Research Hospital, Memphis, USA
Venetoclax chemo combo active and well-tolerated in children with r/r AML ( Dr Seth Karol - St. Jude Children’s Research Hospital, Memphis, USA )
12 Dec 2019

Laser therapy for vulvo-vaginal atrophy / genito-urinary syndrome of menopause in breast cancer survivors

Prof Deborah Fenlon - Swansea University, Swansea, UK
Laser therapy for vulvo-vaginal atrophy / genito-urinary syndrome of menopause in breast cancer survivors ( Prof Deborah Fenlon - Swansea University, Swansea, UK )
12 Dec 2019

Cancer Survivorship - Special Issue

Prof Deborah Fenlon - Swansea University, Swansea, UK
Cancer Survivorship - Special Issue ( Prof Deborah Fenlon - Swansea University, Swansea, UK )
12 Dec 2019